Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
AFYA 
Afya Ltd (AFYA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
02/27/2026: AFYA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $17.51
1 Year Target Price $17.51
| 1 | Strong Buy |
| 2 | Buy |
| 2 | Hold |
| 1 | Sell |
| 3 | Strong Sell |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.23B USD | Price to earnings Ratio 8.69 | 1Y Target Price 17.51 |
Price to earnings Ratio 8.69 | 1Y Target Price 17.51 | ||
Volume (30-day avg) 9 | Beta 0.51 | 52 Weeks Range 13.12 - 19.90 | Updated Date 02/27/2026 |
52 Weeks Range 13.12 - 19.90 | Updated Date 02/27/2026 | ||
Dividends yield (FY) 1.72% | Basic EPS (TTM) 1.56 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.08% | Operating Margin (TTM) 29.88% |
Management Effectiveness
Return on Assets (TTM) 8.35% | Return on Equity (TTM) 16.72% |
Valuation
Trailing PE 8.69 | Forward PE 7.86 | Enterprise Value 1792679527 | Price to Sales(TTM) 0.34 |
Enterprise Value 1792679527 | Price to Sales(TTM) 0.34 | ||
Enterprise Value to Revenue 2.7 | Enterprise Value to EBITDA 6.16 | Shares Outstanding 46894952 | Shares Floating 7894329 |
Shares Outstanding 46894952 | Shares Floating 7894329 | ||
Percent Insiders 68.11 | Percent Institutions 20.59 |
Upturn AI SWOT
Afya Ltd
Company Overview
History and Background
Afya Ltd. was founded in 2009. It is a leading medical education group in Brazil. Significant milestones include its expansion into undergraduate medical programs and the launch of its digital learning platform. The company has evolved from providing continuing medical education to offering a comprehensive suite of educational services across the entire medical career lifecycle.
Core Business Areas
- Undergraduate Medical Schools: Afya operates and maintains a network of accredited undergraduate medical schools in Brazil. These institutions are central to its business, providing the foundational education for future physicians. The company has been actively acquiring and expanding its physical campus footprint.
- Postgraduate and Continuing Medical Education (CME): Afya offers a wide range of postgraduate and continuing medical education programs, including residencies, specializations, and short courses. This segment caters to physicians looking to further their careers and maintain their certifications.
- Digital Learning Platform: The company has invested in a robust digital learning platform that complements its physical offerings. This platform provides access to online courses, virtual classrooms, and educational content, enhancing accessibility and scalability.
Leadership and Structure
Afya Ltd. is led by a management team with deep experience in the education and healthcare sectors. The exact details of the current leadership team can be found in their official investor relations materials. The company is structured to manage its various educational institutions and digital offerings efficiently.
Top Products and Market Share
Key Offerings
- Description: Afya offers full undergraduate medical degrees, a critical and high-demand program. It has a significant market share in Brazil's private medical education sector. Competitors include other private medical school networks and public universities.
- Market Share Data: Afya is a leading player in Brazil's private medical education, but specific market share figures for this exact product are difficult to isolate from broader segment data. The company has been aggressively expanding its capacity.
- Product Name 1: Undergraduate Medical Degrees
- Description: Specialized postgraduate training programs for medical doctors. Afya offers a variety of residency specializations. Competitors include public hospitals and other private educational institutions offering similar programs.
- Market Share Data: Afya holds a substantial position in the private medical residency market in Brazil, serving a significant number of physicians annually.
- Product Name 2: Medical Residency Programs
- Description: Online courses, webinars, and digital educational resources for medical professionals. This segment is growing rapidly. Competitors include other online education providers and professional medical associations.
- Market Share Data: While growing, the specific market share for this digital segment is part of a broader competitive landscape of online learning platforms in healthcare.
- Product Name 3: Digital Medical Courses & Content
Market Dynamics
Industry Overview
The medical education industry in Brazil is characterized by high demand for qualified healthcare professionals, a growing need for specialized medical knowledge, and an increasing adoption of digital learning solutions. Regulatory changes and government policies also play a significant role.
Positioning
Afya is positioned as a leading provider of integrated medical education in Brazil, spanning undergraduate to postgraduate levels and embracing digital transformation. Its key competitive advantages include its established brand, extensive network of physical campuses, strong accreditation, and growing digital capabilities.
Total Addressable Market (TAM)
The TAM for medical education in Brazil is substantial, driven by the country's large population and the ongoing demand for healthcare services. Afya is well-positioned to capture a significant portion of this market, particularly within the private education sector, through its comprehensive offerings and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Leading market position in Brazil's private medical education sector.
- Diversified revenue streams from undergraduate, postgraduate, and digital education.
- Strong brand recognition and reputation.
- Growing digital learning platform capabilities.
- Experienced management team.
- Strategic acquisitions to expand reach and offerings.
Weaknesses
- Dependence on the Brazilian market, making it susceptible to local economic and regulatory changes.
- Significant capital expenditure required for physical campus expansion and acquisitions.
- Integration challenges with acquired entities.
- Competition from established public universities, which often have lower tuition fees.
Opportunities
- Continued expansion of its digital learning offerings and reach.
- Further strategic acquisitions to consolidate the market and enter new segments.
- Growth in demand for specialized medical training and continuing education.
- Leveraging its platform for broader healthcare professional training beyond physicians.
- International expansion opportunities in other Portuguese-speaking markets.
Threats
- Changes in government regulations or accreditation standards for medical education.
- Economic downturns in Brazil impacting student enrollment and ability to pay.
- Increased competition from new entrants or existing players expanding aggressively.
- Technological disruption impacting traditional educational models.
- Potential reputational damage from quality concerns or regulatory issues.
Competitors and Market Share
Key Competitors
- u00c2nima Educau00e7u00e3o S.A. (ANIM3 on B3)
- Cogna Educau00e7u00e3o S.A. (COGN3 on B3)
- YDUQS Participau00e7u00f5es S.A. (YDUQ3 on B3)
Competitive Landscape
Afya's advantages include its focused strategy on medical education and strong brand in that niche. Its disadvantages can arise from the capital intensity of acquisitions and potential integration challenges compared to more diversified education groups.
Major Acquisitions
Several Medical Schools and Educational Institutions (specific names vary and are ongoing)
- Year: 2022
- Acquisition Price (USD millions): Variable (reported in hundreds of millions over several years)
- Strategic Rationale: To expand its footprint in high-demand medical education markets, increase student enrollment, diversify its portfolio of educational offerings, and achieve economies of scale.
Growth Trajectory and Initiatives
Historical Growth: Afya has experienced substantial historical growth, primarily through strategic acquisitions of medical schools and educational institutions, alongside organic expansion of its existing operations. This has led to a rapid increase in its student base and revenue.
Future Projections: Analyst projections for Afya generally indicate continued revenue and earnings growth, supported by its strong market position, ongoing acquisition pipeline, and the increasing demand for medical education in Brazil. The company is expected to further enhance its digital offerings and potentially expand its service portfolio.
Recent Initiatives: Recent initiatives have focused on integrating newly acquired institutions, expanding digital learning capabilities, enhancing the student experience through technology, and optimizing operational efficiencies across its network. Investments in new campuses and program offerings are also ongoing.
Summary
Afya Ltd. is a strong player in Brazil's medical education sector, benefiting from high demand and strategic acquisitions. Its diversified offerings across undergraduate, postgraduate, and digital learning provide a robust growth foundation. Continued focus on integration, digital innovation, and market consolidation will be key to navigating competitive pressures and regulatory changes in the dynamic Brazilian education landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Afya Ltd. Investor Relations Reports (Annual Reports, Quarterly Filings)
- Financial News Websites (e.g., Bloomberg, Reuters, Seeking Alpha)
- Industry Analysis Reports
Disclaimers:
This information is compiled for informational purposes only and does not constitute investment advice. Financial data and market share figures are subject to change and may vary based on reporting methodology and source. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Afya Ltd
Exchange NASDAQ | Headquaters Nova Lima, MG, Brazil | ||
IPO Launch date 2019-07-19 | CEO - | ||
Sector Consumer Defensive | Industry Education & Training Services | Full time employees - | Website https://www.afya.com.br |
Full time employees - | Website https://www.afya.com.br | ||
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.